Physician profile
Beth A Casady
NPI 1720096159
$794.72
in general payments reported to CMS, 2019-2025
17 companies · $50.23 in 2025
The $50.23 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.36 · 2020: $117 · 2021: $45.99 · 2022: $215 · 2023: $192 · 2024: $111 · 2025: $50.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.52 | 2022-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $88.01 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $82.56 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $63.62 | 2020-2023 | Ozempic, Rybelsus |
| Pfizer INC. | $62.55 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.06 | 2022 | |
| Exact Sciences Corporation | $50.76 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $49.43 | 2024-2025 | |
| Dexcom, INC. | $39.96 | 2020 | |
| Shire North American Group INC | $34.66 | 2019 | |
| Abbott Laboratories | $34.50 | 2022-2024 | Freestyle Libre 3 |
| Amgen INC. | $33.74 | 2023-2024 | Repatha, Otezla |
| Kowa Pharmaceuticals America, INC. | $27.66 | 2023-2024 | Seglentis, Livalo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.08 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.76 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $18.74 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Casady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.